Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glibenclamide effect on maternal and neonatal outcomes in women with gestational diabetes
IRCT2013102315045N2Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of glibenclamide in gestational diabetes mellitus (GDM), sponsored by Kashan University of Medical Sciences. Primary endpoints: Maternal outcomes and Neonatal outcomes. Started Mar 2013; status: completed.
02
Drugs
glibenclamide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on IRCT2013102315045N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013102315045N2.